Maurizio Inghilleri

Pubblicazioni

Titolo Pubblicato in Anno
Paraneoplastic neuromyelitis optica spectrum disorder associated with lung adenocarcinoma: a case report FRONTIERS IN MEDICINE 2022
Classical and Unexpected Effects of Ultra-Micronized {PEA} in Neuromuscular Function BIOMOLECULES 2022
Effects of Skin Stimulation on Sensory-Motor Networks Excitability: Possible Implications for Physical Training in Amyotrophic Lateral Sclerosis FRONTIERS IN NEUROLOGY 2022
The Silent Period for Small Fiber Sensory Neuropathy Assessment in a Mixed Cohort of Transthyretin-Mediated Amyloidosis BIOMEDICINES 2022
Effects of 3,4-diaminopyridine on myasthenia gravis: Preliminary results of an open-label study FRONTIERS IN PHARMACOLOGY 2022
Functional and morphometric assessment of small-fibre damage in late-onset hereditary transthyretin amyloidosis with polyneuropathy: the controversial relation between small-fibre-related symptoms and diagnostic test findings AMYLOID 2022
Validation of the DYALS (dysphagia in amyotrophic lateral sclerosis) questionnaire for the evaluation of dysphagia in ALS patients NEUROLOGICAL SCIENCES 2022
Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trial EUROPEAN JOURNAL OF NEUROLOGY 2022
A longitudinal study defined circulating microRNAs as reliable biomarkers for disease prognosis and progression in ALS human patients CELL DEATH DISCOVERY 2021
A case of acute motor and sensory axonal neuropathy mimicking brain death NEUROLOGICAL SCIENCES 2021
Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension NEUROLOGY 2021
The beneficial effect of physiotherapy on the cervical spine mobility of ACDF patients and healthy individuals: An original observational cohort comparison research protocol INTERDISCIPLINARY NEUROSURGERY 2021
ATTRv in Lazio-Italy: A High-Prevalence Region in a Non-Endemic Country GENES 2021
Progressione della disfagia orofaringea nella sclerosi laterale amiotrofica: studio retrospettivo longitudinale. abstract SIOeChF 2021 2021
Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial LANCET NEUROLOGY 2021
Progression of oropharyngeal dysphagia in amyotrophic lateral sclerosis: a retrospective cohort study DYSPHAGIA 2021
Bradykinesia in motoneuron diseases CLINICAL NEUROPHYSIOLOGY 2021
PREVALENCE OF AMYOTROPHIC LATERAL SCLEROSIS IN LATIUM REGION (ITALY) BRAIN AND BEHAVIOR 2021
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology NATURE GENETICS 2021
Validation of the DYALS (dysphagia in amyotrophic lateral sclerosis) questionnaire for the evaluation of dysphagia in ALS patients NEUROLOGICAL SCIENCES 2021

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma